Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis.

Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q46599295

about

Crosstalk between the heart and peripheral organs in heart failure Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies Inflammation in arterial diseases Targeting interleukin-1 in heart disease Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review The Sphinx's riddle: cardiovascular involvement in autoimmune rheumatic disease Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis Evasion of inflammasome activation by microbial pathogens Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms.Inflammation modulation and cardiovascular disease prevention.Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography.Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial.An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes Left ventricular function in treatment-naive early rheumatoid arthritis.Endothelial dysfunction in tristetraprolin-deficient mice is not caused by enhanced tumor necrosis factor-α expression Anti-inflammatory therapies for cardiovascular disease Validated methods for assessment of subclinical atherosclerosis in rheumatology.Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results.The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats.Interleukin expression after injury and the effects of interleukin-1 receptor antagonist Did Dumbo suffer a heart attack? independent association between earlobe crease and cardiovascular disease.Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial Remodeling Preventing Heart Failure in Inflammatory and Immune Disorders Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study].Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade.Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions.Potential novel pharmacological therapies for myocardial remodelling.Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.Anakinra for myocarditis in juvenile idiopathic arthritis.Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease.The role of IL-1 in the pathogenesis of heart disease.Treating inflammation by blocking interleukin-1 in humans.

P2860

Q26766491-0B599A87-852A-4CEA-AB2D-52631B412DF8 Q26776120-0B363DFE-0390-4E7E-8D17-CB4F5EC28ECD Q26799747-B6B9E10B-910A-43AC-BF74-F767721CDEF9 Q26853576-78EA139A-B829-48B4-AF8C-78C3A28394F9 Q27009347-EB20EF12-3D6B-42F2-94DD-A41C8E806879 Q27023183-26D97021-D40D-4945-A2C7-ED81B4212535 Q28069667-7212FF29-AC01-422B-A8B4-03BC86BDED09 Q28072472-06EFDFF2-1EC1-4B73-9770-6B1E423845E2 Q28082757-CB1A0C86-6F8F-4833-A98C-36F0E246E782 Q28731260-ED60CE62-0B27-494E-AED0-C5E6FAC4CBD0 Q30355344-4FDE0D4D-17BB-4D43-9E1F-340E45FB55D1 Q30361151-2D7D0B9D-4190-475C-B1C2-F80DA21E56FD Q30401698-1F7609B1-B797-4917-8420-B6FC7D61318E Q30414961-C591E190-B7AA-4FCE-8057-FB039B62A89C Q30426026-54BE3B78-DE8C-407C-81B3-4D4FA9A57771 Q33523617-BE429099-80AE-47A1-B26B-8BEF6C08AEDF Q33561072-BEDF50A5-8B94-4A1D-9FA6-73CDD3E93148 Q33758866-8A92E1CE-6A46-49D0-80BB-C13776B2C2C0 Q33847043-9E16AC5A-E3B8-4E26-8EEC-3929F918D80A Q34076011-DF755A33-F923-4580-B037-48FB067C4C1B Q34137872-C0803062-8CB2-4BAF-8D4F-FEA82709547C Q34164481-3C33BED7-BAC3-49F1-BFB7-0621381B5B9A Q34219694-D5A255F8-EA75-4C19-8C7A-36F91B45A541 Q34769627-DC72AD20-A5CF-4205-A0D4-01EF7DEB3A8A Q34927037-AABFECD3-76BD-42FE-B3DD-0E5ACFD7FBA1 Q35899244-C2221C7A-10F8-4EB9-BDE5-6ED9FA12354E Q35975645-0546C888-9A44-466A-8690-E301043F18B6 Q35994802-D83F7CD0-15A4-41BA-A31F-5088B779E455 Q36816872-FC3323BD-8C0C-4D70-B0E4-7C24D79E9FEB Q36816882-C10704D2-D9C4-4402-B980-693D52CC53B6 Q36985609-24C0E7DC-CCF2-429D-82E6-C056291E61B7 Q36990716-65A2A3B9-DE96-4CE7-A850-2E71833997A4 Q37141472-EB8C1138-AE15-4291-B8C2-1F7C03D570B0 Q37216087-528D29C9-E951-4091-8E32-4A12437DF6B9 Q37329709-C7AB97C0-C7B0-43E7-9F80-7389012D9CEC Q37338935-8108AE08-A8E1-4F10-BAE1-62691F7D099B Q37369987-C78D8093-F4AC-4FE9-8BAF-59144D78A42B Q37421811-E32F3AB9-637F-4335-AFA2-102AAC980CC1 Q37460270-AC4D6ECB-5BEB-4EB5-A924-61F40650BC79 Q37636664-85212281-D3E9-4795-A0FD-C918EF96A6E5

P2860

Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q46599295

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Inhibition of interleukin-1 by ...... nts with rheumatoid arthritis.

@en

Inhibition of interleukin-1 by ...... nts with rheumatoid arthritis.

@nl

type

label

Inhibition of interleukin-1 by ...... nts with rheumatoid arthritis.

@en

Inhibition of interleukin-1 by ...... nts with rheumatoid arthritis.

@nl

prefLabel

Inhibition of interleukin-1 by ...... nts with rheumatoid arthritis.

@en

Inhibition of interleukin-1 by ...... nts with rheumatoid arthritis.

@nl

P1433

Q46599295-AA81CA09-23C8-47EE-86B9-B4B24DC75743

P1476

Q46599295-C6E310AA-03F8-4286-A3E3-087A1BF5C05A

P2093

Q46599295-0085442A-E6F9-46A4-B2DB-57B5E844AA61

Q46599295-093FF026-0201-47EA-9B5A-9145B85AE772

Q46599295-13681A77-7958-49E6-86B6-EADE3D484D67

Q46599295-1689F731-604A-475B-BC99-C0077B555F09

Q46599295-1F6BE403-842A-4F22-8C7E-7E18ED2EDF03

Q46599295-4CC68664-E905-40C5-8D35-FAC7AA7F2081

Q46599295-8E140B9F-5492-43EE-A77D-9747ED675B74

Q46599295-9CA5979E-42EB-4E43-A5E8-874733350E65

Q46599295-B053321A-8FBA-4A23-BD88-966F372C48DA

Q46599295-C96C4938-C6B2-4629-874B-A40F185BD802

P304

Q46599295-38DF4886-997C-4B9A-BB63-8C24B3FCCC0F

P31

Q46599295-E93E410C-AAF0-4D05-AC41-09805D1C6615

P356

Q46599295-F4C10BFF-C214-4BA1-9688-24EBA6AFF7C1

P407

Q46599295-726B79EB-5AD2-4AFE-A27D-64E6C45ACF18

P433

Q46599295-5CE21137-F41B-46D3-8077-7F2F4C951F72

P478

Q46599295-D607FB15-8FE4-41A5-9648-F0B92E1BE969

P577

Q46599295-EB68B933-26D4-4A78-BF4D-9AE2B7FBA7AA

P698

Q46599295-EF8C316B-1675-4E34-9EC8-4A5E2F2FBEFD

P921

Q46599295-90594AA1-E991-4F2D-850B-15C12DA633C9

Q46599295-9f2c437c-f2f5-463b-bea1-a647770fcb93

P356

CIRCULATIONAHA.107.731877

P1433

P1476

Inhibition of interleukin-1 by ...... nts with rheumatoid arthritis.

@en

P2093

Dimitrios T Kremastinos

http://www.w3.org/2001/XMLSchema#string

Grigorios Skarantavos

http://www.w3.org/2001/XMLSchema#string

Ignatios Ikonomidis

http://www.w3.org/2001/XMLSchema#string

Ioanna Andreadou

http://www.w3.org/2001/XMLSchema#string

Ioannis Paraskevaidis

http://www.w3.org/2001/XMLSchema#string

John P Lekakis

http://www.w3.org/2001/XMLSchema#string

Maria Nikolaou

http://www.w3.org/2001/XMLSchema#string

Panayiotis N Soucacos

http://www.w3.org/2001/XMLSchema#string

Pelagia Katsimbri

http://www.w3.org/2001/XMLSchema#string

Theophania Kaplanoglou

http://www.w3.org/2001/XMLSchema#string

P304

2662-2669

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.107.731877

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18474811

http://www.w3.org/2001/XMLSchema#string

P921